心脏起搏用于心力衰竭已有十余年的历史,心脏再同步化治疗慢性心力衰竭的疗效已得到充分的肯定。然而对于心脏再同步化治疗后仍有部分患者疗效不佳,甚至病情恶化,主要源于对适应证的把握不准。所以其治疗患者的挑选有着严格的筛选,随着研究的深入,适应证也不断改动。本篇综述心脏再同步化治疗适应证的演变。 Cardiac pacing for heart failure has been more than ten years of history, cardiac resynchronization therapy for chronic heart failure has been fully affirmed. However, after cardiac resynchronization therapy, some patients still have poor curative effects or even worse conditions, mainly due to the uncertainty of indications. Therefore, the treatment of patients with the selection of a rigorous screening, with further research, indications are also constantly changing. This review summarizes the evolution of cardiac resynchronization therapy indications.